Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharma Roth GmbH is a German pharmaceutical company headquartered in Wiesbaden that specializes in the manufacture, trade, and distribution of a wide range of pharmaceutical and chemical products. Established in 2000, the company operates as an approved wholesaler and certified GMP manufacturer, focusing on therapeutic areas such as ophthalmology, internal medicine, and the central nervous system. Pharma Roth manages a portfolio of marketing authorizations for products like Opiwar (opipramol) and Dobutamin Pharma Roth, and it actively engages in out-licensing and export activities across Europe, the Middle East, and international markets. The company also provides manufacturing services and collaborates with other European pharmaceutical firms for production and cross-licensing. Its business model emphasizes the acquisition of marketing authorizations to drive its export business through strategic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharma Roth.